2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model.


Patients with asthma experience airway structural changes, termed airway remodeling, in response to persistent inflammation. 2-Methoxyestradiol (2-ME) is an anti-angiogenic agent and downregulates hypoxia-inducible factor 1 (HIF-1) and inhibits HIF-1alpha-induced transcriptional activation of vascular endothelial growth factor (VEGF) expression. We… (More)
DOI: 10.1016/j.clim.2008.07.023

9 Figures and Tables


  • Presentations referencing similar topics